Ascentage Pharma signs R & D, commercialization deal worth up to $245M

Before going public in Hong Kong in October 2019, Ascentage raised nearly $240 million in private investment dollars.
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Source Type: news